Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?
Completed
Conditions studied: Barrett's Esophagus, Intestinal Metaplasia, Gastroesophageal Reflux Disease (GERD)
In brief
The investigators propose a study comparing the morphological and functional aspects of the neosquamous epithelium (NSE) after ablative therapy for dysplastic Barrett's esophagus (BE) to that of native squamous epithelium in normal controls as well as gastroesophageal reflux disease (GERD), non-Barrett's Esophagus (BE) subjects.
Key facts
- Study ID
- NCT01373125
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 99
- Starts
- 2011-06-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2015-09-23
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of North Carolina Chapel Hill — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.